Valneva SE (VALN) Gross Margin (2021 - 2026)

Valneva SE's (VALN) quarterly Gross Margin came in at 14.21% in Q1 2026, down 3837.0% year-on-year from 0.38% in Q1 2025, and up 125.26% quarter-over-quarter from 6.31% in Q4 2025.

Valneva SE (VALN) Gross Margin (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Gross Margin across 6 years of filings, most recently posting 14.21% for Q1 2026.

  • Gross Margin for Q1 2026 came in at 14.21%, down 3837.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 20.93% (down 2369.0% YoY), and the FY2025 annual result was 32.15%, down 751.0% from the prior year.
  • Gross Margin came in at 14.21% for Q1 2026 at Valneva SE, up from 6.31% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 52.58% in Q1 2025 to a low of 817.83% in Q2 2022.
  • The 5-year median for Gross Margin is 31.07% (2024), against an average of 32.91%.
  • Peak annual rise in Gross Margin reached 83449 bps in 2022, while the deepest fall reached 78912 bps in 2022.
  • Valneva SE's Gross Margin stood at 201.45% in 2022, then surged by 122 bps to 45.22% in 2023, then grew by 3 bps to 46.39% in 2024, then slumped by 86 bps to 6.31% in 2025, then surged by 125 bps to 14.21% in 2026.
  • The last three Gross Margin figures came in at 14.21% (Q1 2026), 6.31% (Q4 2025), and 15.76% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 79.04%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 86.85%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 14.21%

Historic Data

Download Data
DateValue
Mar 31, 2026 14.21%
Dec 31, 2025 6.31%
Sep 30, 2025 15.76%
Jun 30, 2025 43.15%
Mar 31, 2025 52.58%
Dec 31, 2024 46.39%
Sep 30, 2024 41.93%
Jun 30, 2024 35.05%
Mar 31, 2024 31.07%
Dec 31, 2023 45.22%
Sep 30, 2023 42.49%
Jun 30, 2023 11.20%
Mar 31, 2023 36.20%
Dec 31, 2022 -201.45%
Sep 30, 2022 23.95%
Jun 30, 2022 -817.83%
Mar 31, 2022 14.24%
Dec 31, 2021 -61.77%
Sep 30, 2021 -810.54%
Jun 30, 2021 -28.71%